Investment Information

Investment InformationCorporate Filings

 
 
No. Date Document Presentation Obligator
1 2020.03.27 Outcome of Annual Shareholders` Meeting Chabiotech Co.,Ltd.
2 2020.03.18 Change of Market Division Chabiotech Co.,Ltd.
3 2020.03.18 Termination of Investment Precaution Issue(내부회계관리제도 비적정 사유 해소 등) Chabiotech Co.,Ltd.
4 2020.03.18 Submission of Audit Report Chabiotech Co.,Ltd.
5 2020.03.12 [Revised]Decision on Calling Shareholders` Meeting Chabiotech Co.,Ltd.
6 2020.03.12 Reporting reasons for holding general shareholders' meeting on the most concentrated date Chabiotech Co.,Ltd.
7 2020.03.12 Decision on Calling Shareholders` Meeting Chabiotech Co.,Ltd.
8 2020.03.06 [Revised]30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations) Chabiotech Co.,Ltd.
9 2020.02.27 30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations) Chabiotech Co.,Ltd.
10 2020.01.15 Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(Enhanced umbilical cord-derived adherent stem cells, method for producing and uses thereof) Chabiotech Co.,Ltd.
 
공시정보 더보기
 
CEO Message
Vision
History
Overseas Corporations
Affiliated Companies
Business Overview
Cord Blood Banking Business
Bio Insurance Business
CHAUM Business(Non-medical)
IT Business
Other Businesses
CHA Biotech R&D Center
R&D Pipeline
Current Status of Clinical Trials
Patent Grants (Korea/Overseas)
Scientific Publications
Corporate Filings
Stock Information
IR Presentations